XML 43 R33.htm IDEA: XBRL DOCUMENT v3.26.1
Share-Based Compensation - Schedule of Share-Based Activity (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2026
Jun. 30, 2025
Number of Options    
Outstanding at beginning of period ( in shares) 5,868,500  
Granted during the period (in shares) 2,330,500  
Forfeited (in shares) (99,926)  
Outstanding at period end (in shares) 8,099,074  
Exercisable at period end (in shares) 2,763,426  
Vested and expected to vest at period end (in shares) 8,099,074  
Weighted Average Exercise Price Per Share    
Outstanding at beginning of period (in dollars per share) $ 1.33  
Granted (in dollars per share) 2.28  
Forfeited (in dollars per share) 1.25  
Outstanding at period end (in dollars per share) 1.60  
Exercisable at period end (in dollars per share) 1.90  
Vested and expected to vest at period end (in dollars per share) $ 1.60  
Weighted Average Remaining Contractual Term (years)    
Outstanding at beginning of period 8 years 6 months 8 years 2 months 12 days
Outstanding at end of period 8 years 6 months 8 years 2 months 12 days
Vested and exercisable at March 31, 2026 6 years 10 months 24 days  
Vested and expected to vest at March 31, 2026 8 years 6 months  
Aggregate Intrinsic Value    
46023 $ 2,941,679  
Outstanding at March 31, 2026 9,468,855  
Vested and exercisable at March 31, 2026 3,218,919  
Vested and expected to vest at March 31, 2026 $ 9,468,855